Clinical Trials for Refractory Nodal Marginal Zone Lymphoma

Find clinical trials for refractory nodal marginal zone lymphoma. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

NCT ID: NCT06905509

This clinical trial is looking at a new treatment approach for patients with large B-cell lymphoma (LBCL) that has either come back after treatment (relapsed) or did not respond to previous therapi...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Sacramento, California, United States

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT ID: NCT06859008

This clinical trial is studying the combination of two medications, zanubrutinib and sonrotoclax, to treat patients from underrepresented racial and ethnic backgrounds who have a type of blood canc...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions